Ashley Pretorius, Arno Lawrenz and Jared Mackenzie

Dr Ashley Pretorius, PhD, is managing director and chief scientific officer of Aminotek, a South African biotechnology company focused on the development of Aptamer technology for diagnostic purposes. He was previously an associate professor at the University of Western Cape (UWC) researching Disease Diagnostics and a post-doctoral fellow of the South African National Bioinformatics Institute (SANBI). Arno Lawrenz, B.Sc (Hons), CFA, is currently the global investment strategist at Ashburton Investments with oversight of Global Multi-Asset funds, and was previously the founder and chief investment officer of Atlantic Asset Management. Dr Jared Mackenzie, PhD, is a medical scientist with extensive experience in several fields including tuberculosis, HIV and malaria. He is currently involved in the study of novel therapeutics for the treatment of Mycobacterium tuberculosis. He has years of experience in diagnostic development for diseases affecting developing countries and is particularly interested in the development of microfluidics-based rapid diagnostics.